Cite
Lindner U, Lawrentschuk N, Schatloff O, et al. Evolution from active surveillance to focal therapy in the management of prostate cancer. Future Oncol. 2011;7(6):775-87doi: 10.2217/fon.11.51.
Lindner, U., Lawrentschuk, N., Schatloff, O., Trachtenberg, J., & Lindner, A. (2011). Evolution from active surveillance to focal therapy in the management of prostate cancer. Future oncology (London, England), 7(6), 775-87. https://doi.org/10.2217/fon.11.51
Lindner, Uri, et al. "Evolution from active surveillance to focal therapy in the management of prostate cancer." Future oncology (London, England) vol. 7,6 (2011): 775-87. doi: https://doi.org/10.2217/fon.11.51
Lindner U, Lawrentschuk N, Schatloff O, Trachtenberg J, Lindner A. Evolution from active surveillance to focal therapy in the management of prostate cancer. Future Oncol. 2011 Jun;7(6):775-87. doi: 10.2217/fon.11.51. PMID: 21675840.
Copy
Download .nbib